O Brien Wealth Partners LLC Sells 138 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

O Brien Wealth Partners LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 56.8% in the fourth quarter, Holdings Channel reports. The fund owned 105 shares of the healthcare conglomerate’s stock after selling 138 shares during the quarter. O Brien Wealth Partners LLC’s holdings in UnitedHealth Group were worth $56,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in UNH. O Dell Group LLC raised its holdings in UnitedHealth Group by 76.9% during the 3rd quarter. O Dell Group LLC now owns 69 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 30 shares during the period. Legend Financial Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter valued at $37,000. Investors Research Corp boosted its stake in shares of UnitedHealth Group by 51.1% during the 4th quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock worth $38,000 after purchasing an additional 24 shares during the period. Bourgeon Capital Management LLC raised its position in UnitedHealth Group by 192.3% in the 4th quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock worth $40,000 after purchasing an additional 50 shares during the period. Finally, WFA of San Diego LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $42,000. 86.31% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 6,160 shares of the stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the transaction, the chief executive officer now owns 86,564 shares of the company’s stock, valued at $42,199,084.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Andrew Witty sold 6,160 shares of the stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the sale, the chief executive officer now directly owns 86,564 shares in the company, valued at $42,199,084.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,008 shares of the business’s stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $484.58, for a total transaction of $488,456.64. Following the transaction, the executive vice president now owns 10,359 shares in the company, valued at $5,019,764.22. The disclosure for this sale can be found here. Insiders sold 8,852 shares of company stock valued at $4,313,962 over the last 90 days. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

UNH traded up $4.54 during trading on Friday, reaching $482.24. 1,179,652 shares of the company’s stock were exchanged, compared to its average volume of 3,303,649. UnitedHealth Group Incorporated has a 1 year low of $449.70 and a 1 year high of $558.10. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.81 and a quick ratio of 0.81. The company’s fifty day simple moving average is $489.68 and its 200-day simple moving average is $499.78. The stock has a market capitalization of $448.98 billion, a P/E ratio of 21.84, a price-to-earnings-growth ratio of 1.39 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating the consensus estimate of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The firm had revenue of $91.93 billion during the quarter, compared to analyst estimates of $89.77 billion. During the same quarter in the previous year, the business earned $5.49 EPS. UnitedHealth Group’s revenue for the quarter was up 14.7% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 24.98 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 21st. Shareholders of record on Monday, March 13th were issued a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a yield of 1.37%. The ex-dividend date was Friday, March 10th. UnitedHealth Group’s payout ratio is 30.18%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on UNH. Piper Sandler assumed coverage on UnitedHealth Group in a report on Thursday. They set an “overweight” rating and a $580.00 price objective for the company. Royal Bank of Canada reissued an “outperform” rating and issued a $592.00 price objective on shares of UnitedHealth Group in a research report on Monday, April 17th. Cantor Fitzgerald started coverage on shares of UnitedHealth Group in a research report on Thursday, April 20th. They set an “overweight” rating and a $591.00 target price on the stock. StockNews.com began coverage on UnitedHealth Group in a report on Thursday, May 18th. They set a “strong-buy” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $617.00 to $627.00 in a research report on Monday, April 17th. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $599.00.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.